| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
From the Departments of Neurology (Drs. Chang, Ernst, Leonido-Yee, and Singer) and Radiology (Drs. Ernst and Walot), University of California Los Angeles School of Medicine, Harbor–UCLA Medical Center, Torrance, CA.
Address correspondence and reprint requests to Dr. Linda Chang, Department of Neurology, 1000 W. Carson Street, B-4, Harbor–UCLA Medical Center, Torrance, CA 90509.
OBJECTIVE: To investigate the relation between biochemical alterations and disease severity in HIV–cognitive motor complex (HIV–CMC).
BACKGROUND: HIV–CMC encompasses both the milder form (HIV–minor cognitive motor disorder [HIV–MCMD]) and the more severe form (HIV–dementia). There is no validated marker to monitor disease severity noninvasively.
METHODS: A total of 54 patients with HIV–CMC (20 with HIV–MCMD, 34 with HIV–dementia) and 29 seronegative healthy volunteers were evaluated for cerebral metabolite abnormalities using proton (1H) MRS in the frontal cortex, frontal white matter, and basal ganglia.
RESULTS: The three subject groups showed different concentrations of myoinositol (MI; p = 0.0005) and choline-containing compounds (CHO; p = 0.004) in the frontal white matter. HIV–dementia patients had metabolite changes in all three brain regions whereas HIV–MCMD patients had abnormalities in the frontal white matter only. HIV–CMC patients had elevated MI (p < 0.0001) and CHO (p = 0.004) levels with increasing AIDS dementia complex stage, and N-acetyl compounds (NA) were decreased only in moderate to severe stages of dementia. Furthermore, CD4 count and CSF viral load, but not plasma viral load, showed significant effects on cerebral metabolite concentrations, which in turn showed significant effects on the HIV–dementia scale.
CONCLUSIONS: In early stages of HIV–CMC, frontal white matter showed evidence of glial proliferation (with elevated MI and CHO levels) and cell membrane injury (with increased CHO levels), but no significant neuronal injury (with normal NA concentrations). HIV–MCMD and HIV–dementia patients have different neurochemical abnormalities. Because these biochemical alterations are related to clinical disease severity, they may be useful surrogate markers for noninvasive quantitative assessment of brain injury in patients with HIV–CMC.
This article has been cited by other articles:
|
|
 |
|
  M. R. Lentz, W. K. Kim, V. Lee, S. Bazner, E. F. Halpern, N. Venna, K. Williams, E. S. Rosenberg, and R. G. Gonzalez Changes in MRS neuronal markers and T cell phenotypes observed during early HIV infection Neurology, April 28, 2009; 72(17): 1465 - 1472. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. G. Pomper and N. Sacktor New Techniques for Imaging Human Immunodeficiency Virus Associated Cognitive Impairment in the Era of Highly Active Antiretroviral Therapy Arch Neurol, September 1, 2007; 64(9): 1233 - 1235. [Full Text] [PDF]
|
|
|
|
 |
|
 R. H. Paul, C. T. Yiannoutsos, E. N. Miller, L. Chang, C. M. Marra, G. Schifitto, T. Ernst, E. Singer, T. Richards, G. J. Jarvik, et al. Proton MRS and Neuropsychological Correlates in AIDS Dementia Complex: Evidence of Subcortical Specificity J Neuropsychiatry Clin Neurosci, August 1, 2007; 19(3): 283 - 292. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Keller, T. N. Venkatraman, M. A. Thomas, A. Deveikis, C. LoPresti, J. Hayes, N. Berman, I. Walot, T. Ernst, and L. Chang Cerebral metabolites in HIV-infected children followed for 10 months with 1H-MRS Neurology, March 28, 2006; 66(6): 874 - 879. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. M. Thurnher, M. Castillo, A. Stadler, A. Rieger, B. Schmid, and P. C. Sundgren Diffusion-Tensor MR Imaging of the Brain in Human Immunodeficiency Virus-Positive Patients AJNR Am. J. Neuroradiol., October 1, 2005; 26(9): 2275 - 2281. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. G. van Gorp and C. H. Hinkin Triple trouble: Cognitive deficits from hepatitis C, HIV, and methamphetamine Neurology, April 26, 2005; 64(8): 1328 - 1329. [Full Text] [PDF]
|
|
|
|
|
|
J. P. Kim, M. R. Lentz, S. V. Westmoreland, J. B. Greco, E. M. Ratai, E. Halpern, A. A. Lackner, E. Masliah, and R. G. Gonzalez Relationships between Astrogliosis and 1H MR Spectroscopic Measures of Brain Choline/Creatine and Myo-Inositol/Creatine in a Primate Model AJNR Am. J. Neuroradiol., April 1, 2005; 26(4): 752 - 759. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Fernandez Ten Myths About HIV Infection and Aids Focus, April 1, 2005; 3(2): 184 - 193. [Full Text] [PDF]
|
|
|
|
 |
|
 T. E. Nordahl, R. Salo, Y. Natsuaki, G. P. Galloway, C. Waters, C. D. Moore, S. Kile, and M. H. Buonocore Methamphetamine Users in Sustained Abstinence: A Proton Magnetic Resonance Spectroscopy Study Arch Gen Psychiatry, April 1, 2005; 62(4): 444 - 452. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Keller, T. N. Venkatraman, A. Thomas, A. Deveikis, C. LoPresti, J. Hayes, N. Berman, I. Walot, S. Padilla, J. Johnston-Jones, et al. Altered neurometabolite development in HIV-infected children: Correlation with neuropsychological tests Neurology, May 25, 2004; 62(10): 1810 - 1817. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. B. Ragin, P. Storey, B. A. Cohen, L. G. Epstein, and R. R. Edelman Whole Brain Diffusion Tensor Imaging in HIV-Associated Cognitive Impairment AJNR Am. J. Neuroradiol., February 1, 2004; 25(2): 195 - 200. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. H. Patel, M. Inglese, G. Glosser, D. L. Kolson, R. I. Grossman, and O. Gonen Whole-Brain N-Acetylaspartate Level and Cognitive Performance in HIV Infection AJNR Am. J. Neuroradiol., September 1, 2003; 24(8): 1587 - 1591. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Wenserski, H.-J. von Giesen, H.-J. Wittsack, A. Aulich, and G. Arendt Human Immmunodeficiency Virus 1-associated Minor Motor Disorders: Perfusion-weighted MR Imaging and H MR Spectroscopy Radiology, July 1, 2003; 228(1): 185 - 192. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. A. Hurley, T. Ernst, K. Khalili, L. Del Valle, I. L. Simone, and K. H. Taber Identification of HIV-Associated Progressive Multifocal Leukoencephalopathy: Magnetic Resonance Imaging and Spectroscopy J Neuropsychiatry Clin Neurosci, February 1, 2003; 15(1): 1 - 6. [Full Text] [PDF]
|
|
|
|
|
|
T. Ernst, L. Chang, J. Jovicich, N. Ames, and S. Arnold Abnormal brain activation on functional MRI in cognitively asymptomatic HIV patients Neurology, November 12, 2002; 59(9): 1343 - 1349. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Ernst, L. Chang, D. Cooray, C. Salvador, J. Jovicich, I. Walot, K. Boone, and R. Chlebowski The Effects of Tamoxifen and Estrogen on Brain Metabolism in Elderly Women J Natl Cancer Inst, April 17, 2002; 94(8): 592 - 597. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N A Sibtain and R J S Chinn Imaging of the central nervous system in HIV infection Imaging, February 1, 2002; 14(1): 48 - 59. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Chang, O. Speck, E. N. Miller, J. Braun, J. Jovicich, C. Koch, L. Itti, and T. Ernst Neural correlates of attention and working memory deficits in HIV patients Neurology, September 25, 2001; 57(6): 1001 - 1007. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H.-J. von Giesen, H.-J. Wittsack, F. Wenserski, H. Koller, H. Hefter, and G. Arendt Basal Ganglia Metabolite Abnormalities in Minor Motor Disorders Associated With Human Immunodeficiency Virus Type 1 Arch Neurol, August 1, 2001; 58(8): 1281 - 1286. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L.M. Smith, L. Chang, M.L. Yonekura, C. Grob, D. Osborn, and T. Ernst Brain proton magnetic resonance spectroscopy in children exposed to methamphetamine in utero Neurology, July 24, 2001; 57(2): 255 - 260. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. R. Berger and G. Arendt HIV dementia: the role of the basal ganglia and dopaminergic systems J Psychopharmacol, May 1, 2000; 14(3): 214 - 221. [Abstract] [PDF]
|
|
|
|
|
|
T. Ernst, L. Chang, M. Leonido-Yee, and O. Speck Evidence for long-term neurotoxicity associated with methamphetamine abuse: A 1H MRS study Neurology, March 28, 2000; 54(6): 1344 - 1349. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Chang, T. Ernst, M. Leonido-Yee, and O. Speck Perfusion MRI detects rCBF abnormalities in early stages of HIV-cognitive motor complex Neurology, January 25, 2000; 54(2): 389 - 389. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Chang, T. Ernst, M. Leonido-Yee, M. Witt, O. Speck, I. Walot, and E. N. Miller Highly active antiretroviral therapy reverses brain metabolite abnormalities in mild HIV dementia Neurology, September 1, 1999; 53(4): 782 - 782. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
